DRI Healthcare Acquires Rosacea Treatment for $46.4 Million October 1, 2021 Auto Bot News 0 DRI Healthcare Trust’s wholly owned subsidiary has acquired a royalty interest in Oracea (doxycycline) for $46.4 million.
